An Innovative Non-invasive Acoustic Approach to Detect and Monitor Cerebral Vasospasm

Exclusion Criteria

• •Local infection in the ear.
• •Pregnant/lactating women
• •Known allergy or hypersensitivity to any of the test materials or contraindication to test materials
• •Subjects currently enrolled in or less than 30 days post-participation in other investigational device or drug study(s), or receiving other investigational agent(s)
• •Any condition that may jeopardize study participation (e.g., abnormal clinical or laboratory finding) or interpretation of study results, or may impede the ability to obtain informed consent (e.g., mental condition) Note: As the trial does not affect the patient's management, there is no limitation regarding patient's medications, previous or post study procedures, etc.
• •Enrolled patients treatment will not change due to their participation in the trial